Pancreatic Cancer Research

ResearcherCapital Medical UniversityNo recent work listed

Yinan Yang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-3847-0679; OpenAlex author ID A5078312489. Sources: OpenAlex.

Their work

Papers
4
Trials
0
Grants
0
Labs led
0
Collaborators
8
Papers, trials and grants by year

2014: 1 paper · 2015: none · 2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: 1 paper · 2021: 1 paper

Papers 4

  1. Gemcitabine potentiates anti-tumor effect of resveratrol on pancreatic cancer via down-regulation of VEGF-B. Co-author DOI 10.1007/s00432-020-03384-7↗
  2. A Case Report of an Ultrasound-Guided and Fluoroscopy-Assisted Posterior Approach for Celiac Plexus Neurolysis in a Patient with Pancreatic Cancer-Associated A… Co-author DOI 10.2147/jpr.s270343↗
  3. Metformin potentiates anti-tumor effect of resveratrol on pancreatic cancer by down-regulation of VEGF-B signaling pathway. Co-author DOI 10.18632/oncotarget.12391↗
  4. Resveratrol plays dual roles in pancreatic cancer cells. Co-author DOI 10.1007/s00432-014-1624-4↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Lei Yang · 3 shared papers, 2014–2021 · strength 0.21
  2. Mengmeng Zhu · 3 shared papers, 2014–2021 · strength 0.21
  3. Zhi Qi · 3 shared papers, 2014–2021 · strength 0.21
  4. Jing Li · 2 shared papers, 2016–2021 · strength 0.17
  5. Rong Shi · 1 shared paper, 2020 · strength 0.16
  6. Yun Wang · 1 shared paper, 2020 · strength 0.16
  7. Wencong Tian · 2 shared papers, 2014–2021 · strength 0.16
  8. Jie Liu · 1 shared paper, 2021 · strength 0.12

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.